Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing is associated with therapeutic response to splicing inhibitor.
Jablonowski C, Quarni W, Singh S, Tan H, Bostanthirige DH, Jin H, Fang J, Chang TC, Finkelstein D, Cho JH, Hu D, Pagala V, Sakurada SM, Pruett-Miller SM, Wang R, Murphy A, Freeman K, Peng J, Davidoff AM, Wu G, Yang J.
Jablonowski C, et al. Among authors: sakurada sm.
bioRxiv [Preprint]. 2023 Nov 20:2023.06.26.546606. doi: 10.1101/2023.06.26.546606.
bioRxiv. 2023.
PMID: 37425900
Free PMC article.
Updated.
Preprint.